Retatrutide
For Research Use Only · Not for Human Consumption
Weight lossMetabolic
Retatrutide is an investigational tri-agonist peptide engaging GIP, GLP-1 and glucagon receptors. Preclinical research explores combined receptor activation on lipolysis, thermogenesis and hepatic glucose output. Supplied as lyophilized powder at ≥98% HPLC purity. For Research Use Only. Not for Human Consumption. Not a drug, food, or cosmetic.
Potential benefits — preclinical research
- •~23% mean body-weight reduction in mid-stage trials — the largest reported for any incretin to date.
- •Triple GIP / GLP-1 / glucagon receptor agonism uniquely targets fat oxidation alongside satiety.
- •Improvements in liver fat, insulin sensitivity and lipid panels in preclinical studies.
- •Reduced knee pain and improved physical function reported in obesity sub-studies.
Findings reported in published in-vitro / animal studies. Not therapeutic claims — for research use only.
Certificate of Analysis
View certificateOut of stock
—per vial